GT
XENT

Glenmede Trust’s Intersect ENT, Inc XENT Stock Holding History

Glenmede Trust’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-38
Closed – – 2476
2020
Q3 		$0 Hold
38
– – ﹤0.01% 2641
2020
Q2 		$0 Sell
38
-77
-67% -$896 ﹤0.01% 2690
2020
Q1 		$2K Hold
115
– – ﹤0.01% 2890
2019
Q4 		$2K Sell
115
-25
-18% -$507 ﹤0.01% 2890
2019
Q3 		$2 Hold
140
– – ﹤0.01% 2884
2019
Q2 		$3 Sell
140
-28
-17% -$755 ﹤0.01% 2799
2019
Q1 		$5 Sell
168
-373
-69% -$11.5K ﹤0.01% 2634
2018
Q4 		$15 Buy
+541
New +$15.8K ﹤0.01% 2120
2017
Q3 		– Sell
-100
Closed -$1K – 2881
2017
Q2 		$1K Hold
100
– – ﹤0.01% 2620
2017
Q1 		$1K Buy
+100
New +$1.4K ﹤0.01% 2620
2016
Q4 		– Sell
-71
Closed -$1K – 2664
2016
Q3 		$1K Hold
71
– – ﹤0.01% 2520
2016
Q2 		$0 Hold
71
– – ﹤0.01% 2752
2016
Q1 		$1K Buy
+71
New +$1.29K ﹤0.01% 2556

Other funds holding XENT

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Glenmede Trust's XENT Position: Q4 2020 in Review

Glenmede Trust sold out of Intersect ENT, Inc (XENT) in Q4 2020, closing a stake of 38 shares.

Glenmede Trust first reported a position in XENT in Q1 2016 and held it in 13 quarters. The position peaked at $2K in Q1 2020. 110 funds tracked by Wall St. Rank hold XENT as of Q4 2020.

  • Glenmede Trust reported no remaining Intersect ENT, Inc position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 38 Intersect ENT, Inc shares in Q4 2020.
  • Glenmede Trust first reported a position in Intersect ENT, Inc in Q1 2016 and held it in 13 quarters.
  • Glenmede Trust's Intersect ENT, Inc position peaked at $2K in Q1 2020.
  • 110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.